IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

COLELLA, ELISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 781
EU - Europa 749
AS - Asia 276
SA - Sud America 8
AF - Africa 5
OC - Oceania 4
Totale 1.823
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 753
GB - Regno Unito 297
CN - Cina 124
IT - Italia 102
SE - Svezia 100
DE - Germania 96
SG - Singapore 53
FI - Finlandia 33
IN - India 33
CA - Canada 28
IE - Irlanda 27
RU - Federazione Russa 23
FR - Francia 20
VN - Vietnam 16
UA - Ucraina 15
BE - Belgio 11
ID - Indonesia 11
HK - Hong Kong 10
KR - Corea 9
DK - Danimarca 6
TR - Turchia 5
AU - Australia 4
BR - Brasile 4
NL - Olanda 4
GR - Grecia 3
JP - Giappone 3
SM - San Marino 3
TH - Thailandia 3
CH - Svizzera 2
ES - Italia 2
ET - Etiopia 2
EU - Europa 2
NO - Norvegia 2
PE - Perù 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
CL - Cile 1
CO - Colombia 1
EG - Egitto 1
IL - Israele 1
IQ - Iraq 1
LK - Sri Lanka 1
ME - Montenegro 1
MY - Malesia 1
NG - Nigeria 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 1.825
Salva come PNG Salva come JPEG
Città #
Southend 277
Chandler 126
Fairfield 71
Seattle 51
Wilmington 48
Ann Arbor 43
Ashburn 40
Princeton 36
Milan 34
Houston 31
Woodbridge 31
Singapore 29
Dublin 27
Beijing 26
Toronto 25
Cambridge 24
Helsinki 23
Boardman 20
Dearborn 20
Hanover 17
Des Moines 16
Kiez 15
Margão 14
Mountain View 13
Dong Ket 12
Brussels 11
Nanjing 11
Bengaluru 10
Phoenix 9
Fremont 8
Jinan 8
New York 8
Redmond 8
Jakarta 7
Los Angeles 7
Santa Clara 6
Shenyang 6
Shenzhen 6
Turin 6
Central District 5
Hong Kong 5
Nanchang 5
Nürnberg 5
Shanghai 5
Frankfurt am Main 4
Hebei 4
Athens 3
Cagliari 3
Cattolica 3
Chicago 3
Eitensheim 3
Evanston 3
Falciano 3
Lissone 3
Mumbai 3
Nuremberg 3
Silver Spring 3
Tianjin 3
Andover 2
Bühl 2
Catanzaro 2
Changsha 2
Fuzhou 2
Haikou 2
Hangzhou 2
Hefei 2
Kent 2
Kunming 2
Leawood 2
Lima 2
Littleton 2
London 2
Montréal 2
Odernheim 2
Portici 2
Redwood City 2
Sakarya 2
Settimo Torinese 2
Somerville 2
Zhengzhou 2
Aachen 1
Alessandria 1
Amsterdam 1
Atlanta 1
Bairnsdale 1
Bangkok 1
Baotou 1
Basra 1
Berlin 1
Bogotá 1
Chengdu 1
Chongqing 1
Clifton 1
Colombo 1
Croydon 1
Cupertino 1
Delray Beach 1
Dubai 1
Durban 1
Edinburgh 1
Totale 1.313
Salva come PNG Salva come JPEG
Nome #
Maraviroc as Intensification Strategy in HIV-1 Positive Patients with Deficient Immunological Response: an Italian Randomized Clinical Trial 252
Maraviroc intensification for HIV-1-positive immunological non-responders (INRs) despite virological suppression during HAART 221
Effectiveness, durability, and safety of darunavir/ritonavir in HIV-1-infected patients in routine clinical practice in Italy : A postauthorization noninterventional study 149
Predictive factors of therapeutic success of a HAART regimen including atazanavir with or without ritonavir in HIV-infected patients 143
Maraviroc : un inibitore del co-recettore CCR5 con un unico profilo di efficacia e tollerabilita’ in diversi scenari clinici dell'infezione da HIV-1 132
Darunavir-cobicistat-emtricitabine-tenofovir alafenamide: safety and efficacy of a protease inhibitor in the modern era 122
ACE inhibitors and ribavirin-associated cough: a common undefined predisposing factor? 116
96-week results of a dual therapy with darunavir/ritonavir plus rilpivirine once a day vs triple therapy in patients with suppressed viraemia: virological success and non-HIV related morbidity evaluation 111
Treatment outcome in HIV+ patients receiving 3- or 4-drug regimens during PHI 96
Factors involved in treatment durability and immunological recovery in a cohort of HIV-positive patients receiving atazanavir-based regimens 91
Factors involved in continuance of atazanavir-based regimens : Results from a cohort of HIV1-positive patients 86
Efficacy, tolerability and virological consequences of long-term use of unboosted atazanavir plus 2 NRTIs in HIV-infected patients 85
Integrase inhibitors use and CMV infection predict immune recovery in peolple living with HIV starting first-line therapy 77
Potential associations between atazanavir exposure and clinical outcome: a pharmacokinetic sub-study from the MODAt randomized trial 70
Hepatitis C virus-related factors associated WITH cognitive performance in HIV-HCV-coinfected patients 69
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting 62
The contribution of immune activation and accelerated aging in multiple myeloma occurring in HIV-infected population 59
null 6
Totale 1.947
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.957
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.957
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020242 0 0 0 39 19 35 33 22 41 30 9 14
2020/2021208 18 14 10 8 17 20 9 34 17 13 28 20
2021/2022239 26 11 5 4 4 15 14 27 39 32 11 51
2022/2023358 46 50 39 38 27 68 4 22 42 1 19 2
2023/2024192 7 21 15 27 33 21 3 11 5 11 16 22
2024/202562 11 45 5 1 0 0 0 0 0 0 0 0
Totale 1.947